Clinical Trials Directory

Trials / Conditions / Ann Arbor Stage III Grade 2 Follicular Lymphoma

Ann Arbor Stage III Grade 2 Follicular Lymphoma

9 registered clinical trials studyying Ann Arbor Stage III Grade 2 Follicular Lymphoma.

StatusTrialSponsorPhase
Active Not RecruitingALX148, Rituximab and Lenalidomide for the Treatment of Indolent and Aggressive B-cell Non-Hodgkin Lymphoma
NCT05025800
M.D. Anderson Cancer CenterPhase 1 / Phase 2
Active Not RecruitingAcalabrutinib, Lenalidomide, and Rituximab for the Treatment of CD20 Positive Stage III-IV, Grade 1-3a Follicu
NCT04404088
M.D. Anderson Cancer CenterPhase 2
CompletedObinutuzumab and Lenalidomide in Treating Patients With Previously Untreated Stage II-IV Grade 1-3a Follicular
NCT02871219
M.D. Anderson Cancer CenterPhase 2
Active Not RecruitingUltra Low Dose Orbital Radiation Therapy in Treating Patients With Stage I-IV Indolent B-cell Lymphoma or Mant
NCT02494700
M.D. Anderson Cancer CenterPhase 2
TerminatedRituximab With or Without Yttrium Y-90 Ibritumomab Tiuxetan in Treating Patients With Untreated Follicular Lym
NCT02320292
Mayo ClinicPhase 3
Active Not RecruitingRituximab, Lenalidomide, and Ibrutinib in Treating Patients With Previously Untreated Stage II-IV Follicular L
NCT01829568
National Cancer Institute (NCI)Phase 1
CompletedOfatumumab and Bendamustine Hydrochloride With or Without Bortezomib in Treating Patients With Untreated Folli
NCT01286272
National Cancer Institute (NCI)Phase 2
CompletedLenalidomide and Rituximab in Treating Patients With Previously Untreated Stage II, Stage III, or Stage IV Fol
NCT01145495
National Cancer Institute (NCI)Phase 2
CompletedLenalidomide in Combination With Rituximab in Treating Participants With Stage III/IV Indolent Non-Hodgkin Lym
NCT00695786
M.D. Anderson Cancer CenterPhase 2